Published in:
01-10-2016 | Radiation Oncology
Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma
Published in: Annals of Surgical Oncology | Issue 11/2016
Login to get accessAbstract
Background
Following wide excision of Merkel cell carcinoma (MCC), postoperative radiation therapy (RT) is typically recommended. Controversy remains as to whether RT can be avoided in selected cases, such as those with negative margins. Additionally, there is evidence that RT can influence survival.
Methods
We included 171 patients treated for non-metastatic MCC from 1994 through 2012 at a single institution. Patients without pathologic nodal evaluation (clinical N0 disease) were excluded to reflect modern treatment practice. The endpoints included local control (LC), locoregional control (LRC), disease-free survival (DFS), overall survival (OS), and disease-specific survival (DSS).
Results
Median follow-up was 33 months. Treatment with RT was associated with improved 3-year LC (91.2 vs. 76.9 %, respectively; p = 0.01), LRC (79.5 vs. 59.1 %; p = 0.004), DFS (57.0 vs. 30.2 %; p < 0.001), and OS (73 vs. 66 %; p = 0.02), and was associated with improved 3-year DSS among node-positive patients (76.2 vs. 48.1 %; p = 0.035), but not node-negative patients (90.1 vs. 80.8 %; p = 0.79). On multivariate analysis, RT was associated with improved LC [hazard ratio (HR) 0.18, 95 % confidence interval (CI) 0.07–0.46; p < 0.001], LRC (HR 0.28, 95 % CI 0.14–0.56; p < 0.001), DFS (HR 0.42, 95 % CI 0.26–0.70; p = 0.001), OS (HR 0.53, 95 % CI 0.31–0.93; p = 0.03), and DSS (HR 0.42, 95 % CI 0.26–0.70; p = 0.001). Patients with negative margins had significant improvements in 3-year LC (90.1 vs. 75.4 %; p < 0.001) with RT. Deaths not attributable to MCC were relatively evenly distributed between the RT and no RT groups (28.5 and 29.3 % of patients, respectively).
Conclusions
RT for MCC was associated with improved LRC and survival. RT appeared to be beneficial regardless of margin status.